The Antidepressant Effect of the Total Flavonoids Extracted fromCottonseed and its Regulation on Hippocampal Monoamines

Abstract

Abstract:Objective：To explore the antidepressant effect of the total flavonoids extracted from cottonseed (CTN-T) and its possible mechanism.Methods：The learned helplessness model in rats was used to evaluate the antidepressant effect of CTN-T. Using the 5-hydroxytryptophan（5-HTP）induced head twitch response test and yohimbine toxicity potentiation test in mice，the possible monoamine targets of the antidepressant action of CTN-T were detected. Moreover， high performance liquid chromatography and electrochemical detection (HPLC-ECD) was used to determine the content of monoamine and metabolites in the hippocampus of rats following CTN-T administration.Results：Repeated administration of CTN-T (50，100 mg·kg^-1，ig，twiceper day for 4 d) significantly decreased the helplessness behavior induced by inescapable foot- shock in learned helplessness test in rats. Repeated administration of CTN-T (50，75 mg·kg^-1， ig，twice per day for 4 d) significantly increased the 5-HTP induced head twitch response in mice，while CTN-T (60 mg·kg^-1，ig，twice per day for 4 d) had a tendency to potentiate yohimbine toxicity in mice. Repeated administration of CTN-T (25~75 mg·kg^-1，ig，twice per day for 4 d)，the neurochemical assays showed that the content of 5-hydroxytryptamine (5-HT) was increased in rat hippocampus at 25 and 100 mg·kg^-1dose of CTN-T，and that the content of norepinephrine (NE) was increased at 50 and 100 mg·kg^-1dose of CTN-T. By contrast，CTN-T had no effects on the content of dopamine (DA)，epinephrine (E)，5-hydroxyindolacetic acid (5-HIAA) and the rate of 5-HT/5-HIAA.Conclusion：CTN-T exerts antidepressant effects which may be closely related to the strengthening of the hippocampal serotonergic and noradrenergic function.

Key words:depression,totalflavonoids extracted from cottonseed（CTN-T）,learnedhelplessness model,5-hydroxytryptamine（5-HT）,norepinephrine（NE）

CLC Number:

R971
R749.42

ZHAO Nan，ZHANG You-zhi，YANG Ming，WANG Yi-wen，ZHAO Yi-min，GONG Ze-hui，LI Yun-feng. The Antidepressant Effect of the Total Flavonoids Extracted fromCottonseed and its Regulation on Hippocampal Monoamines[J]. Acta Neuropharmacologica, 2011, 1(4): 6-11.

References

1 Murray CJL, Lopez AD. The global burden of disease [M]. Boston: Harvard University Press, 1996.
2 Hirschfeld RM.History and evolution of the monoamine hypothesis of depression[J]. J Clin Psychiatry, 2000, 61 (Suppl 6):4-6.
3 Patrick Schloss, Fritz A Henm. New insights into the mechanisms of antidepressant therapy [J]. Pharmacol Therapeut, 2004, 102(1):47-60.
4 李云峰，袁莉，杨明,等. 棉籽总黄酮抗抑郁作用的研究[J]．中国药理学通报，2006，22（1）：841-844.
5 Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss [J]. Am J Psychiatry, 2003, 160(8):1516-1518.
6 Glenda M. MacQueen, Campbell Stephanie, Bruce S.McEwen,et al. Course of illness, hippocampal function, and hippocampal volume in major depression [J]. Proc Natl Acad Sci, 2003, 100(3):1387-1392.
7 徐锐，杨明，赵毅民. 双波长分光光度法测定棉籽提取物中黄酮苷含量[J]. 解放军药学学报，2007，23（3）: 212-214.
8 张有志，李云峰，刘刚，等. 巴戟天寡糖对获得性无助抑郁模型大鼠行为的影响[J].中国行为医学科学，2005，14（4）：309-311.
9 Bhattacharya SK, Chakrabarti A, Chatterjee SS. Activity profiles of two hyperforin-containing hypericum extracts in behavioral models [J]. Pharmaco- psychiatry, 1998, 31( Suppl 1) : 22 - 29.
10 Joelle Meignen, Annick Grognet, Marie-Jeanne Deniard,et al. Pharmacological comparison of the potential antidepressant UP 614-04 with viloxazine and imipramine; behavioral studies[J]. Gen Pharmacol, 1982, 13(5) : 381 -391.
11 唐琴梅，屈志炜. HPLC-EC检测单胺类神经递质及其代谢产物[M]//张均田.现代药理实验方法（上册）. 第一版. 北京：医科大学中国协和医科大学联合出版社，1998，611.
12 李恺，陈红霞，袁莉，等. 新型5-HT_1A受体激动和5-HT重摄取抑制双重活性化合物YL-0919抗抑郁作用的行为学评价[J]. 国际药学研究杂志，2010，37（5）：366- 371.
13 Seligman ME, Beagley G. Learned helplessness in the rat [J]. J Comp Physiol Psychol, 1975, 88(2):534-541.
14 Martin P, Soubrie P, Simon P. Shuttle-box deficits induced by inescapable shocks in rats: reversal by the beta-adrenoceptor stimulants clenbuterol and salbutamol [J]. Pharmacol Biochem Behav,1986, 24(2):177-181.
15 Willner Paul. Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case [J]. Prog Neuropsychopharmacol Biol Psychiatry, 1986, 10(6):677-690.
16 Alan I.Leshner, Helga Remler, Anat Biegon,et al. Desmethylimipraminc (DMI) counteracts learned helplessness in rats [J]. Psychopharmacology (Berl), 1979 , 66 (2):207-208.
17 Sherman AD, Sacquiten JL, Petty F. Specificity of the learned helplessness model of depression [J]. Pharmcol Biochem Behav,1982, 16(3):449-454.
18 Kametani H, Nomura S, Shimizu J. The reversal effect of antidepressants on the escape deficit induced by inescapable shock in rats [J]. Psychopharmacology (Berl),1983,80(3):206-208.
19 赵楠，李云峰，杨红菊，等. 棉籽总黄酮在大鼠慢性应激模型中的抗抑郁活性及其对海马神经营养通路的影响 [J]. 中国药理学与毒理学杂志，2007，21（3）：179-184.

[1]	XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin.Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8.
[2]	MO Cui-ying, LUO Guo-ping.Influence of Nimergoline Combined with Trasylin and Psychotherapy for Depression in Patients with Post-stroke Depression[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 7-10.
[3]	FU Zhi-jiang1，GAO Yun2，ZHANG Wei3，LIU Zong-chao1，4，ZHANG Hua-wen4，LIU Shi-gui1，HUANG Chen-yi1，GAO Yin5，GAO Hai-ming1.Effects and Mechanisms of Depression on Bone Fracture Healing in Rats[J]. Acta Neuropharmacologica, 2018, 8(6): 1-8.
[4]	FU Zhi-jiang1，LIU Yong1，GAO Yin1，ZHANG Wei2，GAO Yun2，LIU Zong-chao1*.Effects and Mechanisms of Depression on Bone Fracture Healing in Rats[J]. Acta Neuropharmacologica, 2018, 8(4): 5-6.
[5]	LIANG Jian-hui1,2*, LIANG hui2, CHENG tao1, LIU Xiao-yan1, Simon M.Y.Lee3, TANG Ben-qin3, WANG Xiu-fen3, CHEN Feng4,Andrew J. Lawrence4.Comorbidity of Anxiety and Depression Induced by Liang’s Contextual-Stress Box in Mice[J]. Acta Neuropharmacologica, 2018, 8(4): 44-45.
[6]	ZAN Gui-ying，SUN Xiang，LI Qing-lin，LIU Jing-gen.Research Progress of the Role and Underlying Mechanism of Dynorphin/κ Opioid Receptor in the Development of Depression[J]. Acta Neuropharmacologica, 2018, 8(1): 54-64.
[7]	LIANG Hui，CHENG Tao，LIANG Jian-hui.Progress in the Comorbidity of Depression and Anxiety[J]. Acta Neuropharmacologica, 2017, 7(6): 30-35.
[8]	ZHANG Kuo，YANG Jing-yu，WU Chun-fu.Progress on Pathophysiology and Animal Models of Depression[J]. Acta Neuropharmacologica, 2017, 7(4): 8-16.
[9]	REN Qian,WANG Zhen-zhen,CHEN Nai-hong.Regulation of Neuroplasticity by MicroRNA in Depression Disorder[J]. Acta Neuropharmacologica, 2017, 7(3): 12-20.
[10]	DU Guan-tao， LIN Jing-ran,LIU Guang-jun， HONG Hao.Research Progress on the Correlation Between Alzheimer’s Disease and Depression[J]. Acta Neuropharmacologica, 2016, 6(6): 40-44.
[11]	CAO Li-hua，BAI Ming，FANG Xiao-yan，WANG Can，MIAO Ming-san.Analysis of Animal Models of Depression Based on Clinical Symptoms[J]. Acta Neuropharmacologica, 2016, 6(4): 19-23.
[12]	ZHANG Xiao-ling，WANG Zhen-zhen，WEN Lu，SHAO Qian-hang，CHEN Nai-hong.The Relationship between Cytokines and Depression[J]. Acta Neuropharmacologica, 2016, 6(4): 31-36.
[13]	WANG Sha-sha，ZHANG Zhao，ZHANG Mei-jin，HU Jin-feng，CHEN Nai-hong.Advances of Nrf 2/ARE Signaling Pathway in the Major Depression Disorder[J]. Acta Neuropharmacologica, 2016, 6(3): 32-37.
[14]	HE Hai-ran，XUE Zhan-xia.Research Progress in the Pathogenesis of Depression[J]. Acta Neuropharmacologica, 2016, 6(2): 20-25.
[15]	JIANG Xiang-yun，SHANG Chao，LI Lei，SUN Shu-zheng，LI Yun-feng，WANG Heng-lin.Allopregnanolone as a New Therapeutic Target for Depression and Anxiety[J]. Acta Neuropharmacologica, 2016, 6(2): 26-30.